Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| VOLITIONRX LTDVNRX · Entity 8241 | Director | February 26, 2026 | February 27, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
VOLITIONRX LTD
Report date February 26, 2026 · Filed February 27, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 252,948 |
Reported balance
After 2026-02-26 transaction · row 1
1 source rowRow 1 · 2026-02-26 · Grant · Acquired 178,000 · Balance 252,948 F1: On February 26, 2026, the reporting person was awarded 178,000 restricted stock units ("RSUs") under the Issuer's 2024 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs will be earned in twelve approximately equal monthly installments commencing on February 1, 2026. Once earned, they will remain subject to additional time-based vesting in a single installment on February 26, 2027, and are generally subject to continued service by the reporting person throughout each applicable earning and vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have been both earned and vested as of the vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: On February 26, 2026, the reporting person was awarded 178,000 restricted stock units ("RSUs") under the Issuer's 2024 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs will be earned in twelve approximately equal monthly installments commencing on February 1, 2026. Once earned, they will remain subject to additional time-based vesting in a single installment on February 26, 2027, and are generally subject to continued service by the reporting person throughout each applicable earning and vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have been both earned and vested as of the vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 26, 2026 Filed Feb 27, 2026 21:32 UTC | VOLITIONRX LTD VNRX · Entity 8241 | GrantCommon Stock | 178,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001477932-26-001104 · form4.xml · nonDerivative · entry 1 Rubin Ethel · CIK 0002038290 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 252,948 F1 · shares: On February 26, 2026, the reporting person was awarded 178,000 restricted stock units ("RSUs") under the Issuer's 2024 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs will be earned in twelve approximately equal monthly installments commencing on February 1, 2026. Once earned, they will remain subject to additional time-based vesting in a single installment on February 26, 2027, and are generally subject to continued service by the reporting person throughout each applicable earning and vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have been both earned and vested as of the vesting date. Read SEC document |
| January 22, 2026 Filed Jan 23, 2026 21:08 UTC | VOLITIONRX LTD VNRX · Entity 8241 | GrantCommon Stock | 12,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001477932-26-000373 · form4.xml · nonDerivative · entry 1 Rubin Ethel · CIK 0002038290 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,948 F1 · shares: On March 17, 2025, the reporting person was awarded 40,000 restricted stock units ("RSUs") under the Issuer's 2024 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to June 30, 2025 and December 31, 2025 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 12,000 RSUs vesting. The RSUs are further subject to a 3-year time-based vesting schedule, vesting in three equal installments of 4,000 units on each of March 17, 2026, 2027 and 2028, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested. The rights with respect to the remaining 28,000 RSUs did not vest and were cancelled on June 30, 2025 and January 22, 2026, respectively. Read SEC document |
| August 15, 2025 Filed Aug 19, 2025 20:05 UTC | VOLITIONRX LTD VNRX · Entity 8241 | GrantCommon Stock | 17,424 | $0.00 | $0.00 |
DisclosureSEC source: 0001477932-25-006097 · form4.xml · nonDerivative · entry 1 Rubin Ethel · CIK 0002038290 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,948 F1 · shares: On August 15, 2025, the reporting person was awarded 17,424 restricted stock units ("RSUs") under the Issuer's 2015 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs are earned in six approximately equal monthly installments commencing on August 1, 2025. Once earned, they will remain subject to additional time-based vesting in two equal installments of 8,712 units on each of November 1, 2025 and February 1, 2026, respectively, and are generally subject to continued service by the reporting person throughout each applicable earning and vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have been earned and vested as of the applicable vesting date. Read SEC document |
| June 01, 2025 Filed Jun 3, 2025 20:05 UTC | VOLITIONRX LTD VNRX · Entity 8241 | GrantCommon Stock | 11,983 | $0.00 | $0.00 |
DisclosureSEC source: 0001477932-25-004364 · form4.xml · nonDerivative · entry 1 Rubin Ethel · CIK 0002038290 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,524 F1 · shares: On June 1, 2025, the reporting person was awarded 11,983 restricted stock units ("RSUs") under the Issuer's 2015 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs partially vest in three installments of 3,995 units, 3,994 units, and 3,994 units on each of June 1, 2025, July 1, 2025 and August 1, 2025, respectively, are also subject to further time-based vesting in a single installment on August 1, 2025, and are generally subject to continued service throughout each applicable vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested. Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 21:01 UTC | VOLITIONRX LTD VNRX · Entity 8241 | GrantCommon Stock | 9,893 | $0.00 | $0.00 |
DisclosureSEC source: 0001477932-25-001459 · form4.xml · nonDerivative · entry 1 Rubin Ethel · CIK 0002038290 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,541 F1 · shares: On March 1, 2025, the reporting person was awarded 9,893 restricted stock units ("RSUs") under the Issuer's 2024 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs partially vest in three installments of 3,298 units, 3,298 units, and 3,297 units on each of March 1, 2025, April 1, 2025 and May 1, 2025, respectively, are also subject to further time-based vesting in a single installment on March 1, 2026, and are generally subject to continued service throughout each applicable vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested. Read SEC document |
| December 01, 2024 Filed Dec 3, 2024 21:01 UTC | VOLITIONRX LTD VNRX · Entity 8241 | GrantCommon Stock | 8,648 | $0.00 | $0.00 |
DisclosureSEC source: 0001477932-24-007806 · form4.xml · nonDerivative · entry 1 Rubin Ethel · CIK 0002038290 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,648 F1 · shares: On December 1, 2024, the reporting person was awarded 8,648 restricted stock units ("RSUs") under the Issuer's 2015 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs partially vest in three installments of 2,883 units, 2,883 units, and 2,882 units on each of December 1, 2024, January 1, 2025 and February 1, 2025, respectively, are also subject to further time-based vesting in a single installment on July 1, 2025, and are generally subject to continued service throughout each applicable vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested. Read SEC document |
| September 30, 2024 Filed Sep 30, 2024 20:38 UTC | VOLITIONRX LTD VNRX · Entity 8241 | GrantCommon Stock | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001477932-24-006042 · form4.xml · nonDerivative · entry 1 Rubin Ethel · CIK 0002038290 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,000 F1 · shares: The reporting person received 15,000 restricted stock units ("RSUs") under the Issuer's 2015 Stock Incentive Plan, vesting in three equal installments of 5,000 units on each of September 30, 2025, September 30, 2026 and September 30, 2027, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.